NEW YORK, August 7, 2026, 06:14 EDT — U.S. premarket hours; normal trading was not underway.
- POET rose 7.0% to $9.13 in premarket trading, pushing its increase over five sessions to 30.6%.
- Estimated pro forma net liquidity stands at approximately $815.7 million, representing 51.8% of the implied equity value.
- Applied Optoelectronics reported an 86% surge in quarterly revenue, underscoring robust demand for optical-networking.
Shares of POET Technologies Inc. NASDAQ:POET advanced 7.0% to $9.13 during premarket trading on Friday, reflecting an implied market capitalization of nearly $1.58 billion. The company’s reported revenue through March totaled $1.41 million.
The altered balance sheet shifts the investment outlook. With reduced financing pressure, the main challenge now lies in order conversion.
Estimated pro forma net liquidity stood at roughly $815.7 million, representing 51.8% of implied equity value. The figure combines liquidity from March with proceeds from the May offering and deducts March liabilities. It does not account for later use of cash.
The increase contributed to a wider rally among optical-equipment stocks. Applied Optoelectronics Inc. NASDAQ:AAOI was the top performer in premarket trading. Lumentum Holdings Inc. NASDAQ:LITE and Coherent Corp. NYSE:COHR moved higher as well.
| Company | Aug. 6 close | Daily move | Aug. 7 premarket | Premarket move |
|---|---|---|---|---|
| POET Technologies NASDAQ:POET | $8.53 | up 5.44% | $9.13 | rising 7.03% |
| Applied Optoelectronics NASDAQ:AAOI | $124.22 | down 3.38% | $141.79 | up 14.14% |
| Lumentum NASDAQ:LITE | $838.06 | up 1.43% | $878.50 | climbing 4.83% |
| Coherent NYSE:COHR | $334.22 | gained 1.83% | $349.29 | up 4.51% |
Prices shown were accessible at approximately 06:14 EDT.
AAOI reported a new demand update, posting an 86% year-on-year increase in second-quarter revenue to $191.9 million. Data-center revenue climbed 140%, reaching $107.7 million. For the third quarter, the company forecast sales in the range of $255 million to $290 million.
The group also acted in anticipation of a potential policy boost. Reuters said U.S. officials were preparing limits on upcoming Chinese optical-transceiver models. The plan is still in early stages and might be revised or dropped.
POET’s capital resources now significantly exceed its disclosed operational size.
| POET financial comparison | Amount |
|---|---|
| Revenue for Q1 2026 | $0.503 million |
| Reported revenue for previous four quarters | $1.411 million |
| Operating cash used in Q1 | $8.810 million |
| Cash and short-term investments as of March 31 | $429.136 million |
| Anticipated net proceeds from May fundraising | $399.676 million |
| Pro forma preliminary net liquidity | $815.684 million |
| Estimated equity value at $9.13 | $1.576 billion |
| Net liquidity as percent of equity value | 51.8% |
| Equity value relative to net liquidity/revenue | 538 times |
The initial figures are based on company reports and the premarket share price. Second-quarter expenditures and additional balance-sheet movements are not included. The resulting ratio does not represent a standard enterprise-value multiple.
Following provisional net liquidity adjustments, investors are valuing POET’s operating business and growth prospects at approximately $760 million. This equates to roughly 538 times the company’s trailing reported revenue. Achieving this premium will demand a significant increase in production.
POET’s Lumilens deal serves as the primary link. In May, POET revealed a first purchase order valued at $50 million and stated the broader five-year potential may surpass $500 million. Realized revenue will depend on development, qualification, and production scaling.
Chief Executive Suresh Venkatesan stated the funding boost reinforced the company’s commercial standing. “Having a strong balance sheet enhances POET’s credibility,” he said. POET intends to expand its production capacity by about ten times through 2027. POET Technologies
Analyst sentiment stays positive, though POET’s sample size is limited.
| Company | Buy | Hold | Sell | Average target | Upside from Aug. 6 close |
|---|---|---|---|---|---|
| POET Technologies NASDAQ:POET | 1 | 0 | 0 | $20.25 | 137.4% |
| Applied Optoelectronics NASDAQ:AAOI | 3 | 2 | 0 | $144.30 | 16.2% |
| Lumentum NASDAQ:LITE | 7 | 3 | 0 | $1,033.89 | 23.4% |
| Coherent NYSE:COHR | 4 | 2 | 0 | $415.00 | 24.2% |
POET’s target gap is based on just one existing Buy rating, leaving its consensus weaker compared to its peers. Snapshots from providers may reflect varying coverage periods.
The sector faces more scrutiny in the week ahead. Lumentum is set to post results after the close on Tuesday, with Coherent reporting following Wednesday’s market session. Updates from both are expected to provide further insight into AI network demand.
Execution risks persist. Delays in qualification, slow pace of turning orders, increased expenses during scale-up, and warrant-related dilution could pressure the cash-adjusted outlook. Additionally, possible U.S. curbs on Chinese suppliers might be reversed.
On Friday, traders will watch if the premarket advance is sustained. Looking further ahead, POET requires booked revenue instead of more funding to justify the premium.
Related articles: NASDAQ:POET
